Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer

International Journal of Clinical Oncology

Volumn 17, Issue 3, 2012, Pages 240-249

  Khanh, Do Trong ^a   Mekata, Eiji ^a   Mukaisho, Ken Ichi ^a   Shimizu, Tomoharu ^a   Tatsuta, Takeshi ^a   Sugihara, Hiroyuki ^a   Endo, Yoshihiro ^a   Kurumi, Yoshimasa ^a   Tani, Tohru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Adjuvant therapy; CD10; CD11b; CD15; Colorectal cancer; High risk stage II

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD163 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; TS 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CELL LINEAGE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD15; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; FUCOSYLTRANSFERASES; HUMANS; MALE; MIDDLE AGED; MYELOID CELLS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPRILYSIN; PROGNOSIS; TREATMENT OUTCOME;

EID: 84862896764     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0281-8     Document Type: Article

References (33)

1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71-96
2. Greene FL, Stewart AK, Norton HJ (2002) A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 236(4):416-421
3. Lin CC, Lin JK, Chang SC et al (2009) Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis 24(6):665-676
4. Köhne CH (2006) Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? Against the proposal. Lancet Oncol 7(6):516-517
5. Sobrero A (2006) Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal. Lancet Oncol 7(6):515-516
6. Greaves MF, Hariri G, Newman RA et al (1983) Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood 61:628-639
7. McIntosh GG, Lodge AJ, Watson P et al (1999) NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154(1):77-82
8. Yasuda M, Itoh J, Satoh Y et al (2005) Availability of CD10 as a histopathological diagnostic marker. Acta Histochem Cytochem 38(1):17-24
9. Fujimoto Y, Nakanishi Y, Sekine S et al (2005) CD10 expression in colorectal carcinoma correlates with liver metastasis. Dis Colon Rectum 48(10):1883-1889
10. Yao T, Tsutsumi S, Akaiwa Y et al (2001) Phenotypic expression of colorectal adenocarcinomas with reference to tumor development and biological behavior. Jpn J Cancer Res 92:755-761
11. Huang WB, Zhou XJ, Chen JY et al (2005) CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis. Jpn J Clin Oncol 35(5):245-250
12. Ogawa H, Iwaya K, Izumi M et al (2002) Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 33(8):806-811
13. Nakamori S, Kameyama M, Imaoka S et al (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53(15):3632-3637
14. Nakamori S, Kameyama M, Imaoka S et al (1997) Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum 40(4):420-431
15. Ohji Y, Yao T, Eguchi T et al (2007) Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep 17(3):525-530
16. Sato Y, Itoh F, Hinoda Y et al (1996) Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon. J Gastroenterol 31(1):12-17
17. Connelly JC, Chambless R, Holiday D et al (1993) Up-regulation of neutral endopeptidase (CALLA) in human neutrophils by granulocyte-macrophage colony-stimulating factor. J Leukoc Biol 53(6):685-690
18. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867
19. Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumor growth and spread. Br J Cancer 90(11):2053-2058
20. Arias JI, Aller MA, Arias J (2007) Cancer cell: using inflammation to invade the host. Mol Cancer 6:29
21. Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454(7203):436-444
22. Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J et al (2000) Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 88(7):1544-1548
23. Klintrup K, Mäkinen JM, Kauppila S et al (2005) Inflammation and prognosis in colorectal cancer. Eur J Cancer 41(17):2645-2654
24. Serafini P, Borrello I, Bronte V (2006) Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 16(1):53-65
25. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182(8): 4499-4506
26. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3):162-174
27. Shojaei F, Zhong C, Wu X et al (2008) Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18(8):372-378
28. Murdoch C, Muthana M, Coffelt SB et al (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618-631
29. Zumsteg A, Baeriswyl V, Imaizumi N et al (2009) Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4(9):e7067
30. Hall PA, D'Ardenne AJ (1987) Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of the published literature. J Clin Pathol 40:1298-1304
31. Fujita S, Taniguchi H, Yao T et al (2010) Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression. Int J Colorectal Dis 25(6): 681-686
32. Braun MP, Martin PJ, Ledbetter JA et al (1983) Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood 61(4):718-725
33. Demirci U, Coskun U, Sancak B et al (2009) Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colo-rectal carcinoma? Asian Pac J Cancer Prev 10(6):1021-1024